Form 4 for PG Procter & Gamble
Accepted 2022-08-24 00:00:00 ET · period of report 2022-08-23 · accession 0001127602-22-021507 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-24 | 2022-08-23 | PG | Davis Jennifer L. | CEO - Health Care | M - OptEx | $91.07 | +27.8K | 60.7K | +85% | +$2.53M |
| D | 2022-08-24 | 2022-08-23 | PG | Davis Jennifer L. | CEO - Health Care | S - Sale+OE | $147.95 | -27.8K | 32.9K | -46% | -$4.11M |
| D | 2022-08-24 | 2022-08-23 | PG | Davis Jennifer L. | CEO - Health Care | M - OptEx | $0.00 | -27.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-23 | M | A | 27,809 | $91.07 | 60,703.79 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-23 | S | D | 27,809 | $147.95 | 32,894.79 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-08-23 | M | D | 27,809 | $0.00 | 0 | D | $91.07 · 2020-02-28 to 2027-02-26 | 27,809 Common Stock |